These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15212156)

  • 21. The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes.
    van Berkel TJ; Kruijt JK; Spanjer HH; Nagelkerke JF; Harkes L; Kempen HJ
    J Biol Chem; 1985 Mar; 260(5):2694-9. PubMed ID: 2579071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
    Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
    Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems.
    Takino T; Koreeda N; Nomura T; Sakaeda T; Yamashita F; Takakura Y; Hashida M
    Biol Pharm Bull; 1998 May; 21(5):492-7. PubMed ID: 9635506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
    Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
    Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific targeting of high density lipoproteins to liver hepatocytes by incorporation of a tris-galactoside-terminated cholesterol derivative.
    van Berkel TJ; Kruijt JK; Kempen HJ
    J Biol Chem; 1985 Oct; 260(22):12203-7. PubMed ID: 4044592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations.
    Takino T; Nakajima C; Takakura Y; Sezaki H; Hashida M
    J Drug Target; 1993; 1(2):117-24. PubMed ID: 8069549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
    Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s.
    Shimada K; Kamps JA; Regts J; Ikeda K; Shiozawa T; Hirota S; Scherphof GL
    Biochim Biophys Acta; 1997 Jun; 1326(2):329-41. PubMed ID: 9218563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
    Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
    Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice.
    Kawakami S; Hattori Y; Lu Y; Higuchi Y; Yamashita F; Hashida M
    Pharmazie; 2004 May; 59(5):405-8. PubMed ID: 15212310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
    Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.
    Opanasopit P; Higuchi Y; Kawakami S; Yamashita F; Nishikawa M; Hashida M
    Biochim Biophys Acta; 2001 Mar; 1511(1):134-45. PubMed ID: 11248212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The distribution of azidothymidine palmitate galactosylated liposomes in mice].
    Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L
    Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
    Wijagkanalan W; Kawakami S; Takenaga M; Igarashi R; Yamashita F; Hashida M
    J Control Release; 2008 Jan; 125(2):121-30. PubMed ID: 18037185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats.
    Spanjer HH; van Berkel TJ; Scherphof GL; Kempen HJ
    Biochim Biophys Acta; 1985 Jun; 816(2):396-402. PubMed ID: 3890947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants.
    Vuaridel-Bonanomi ES; Weder HG
    J Microencapsul; 1991; 8(2):203-14. PubMed ID: 1765900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice.
    Chansri N; Kawakami S; Yamashita F; Hashida M
    Int J Pharm; 2006 Sep; 321(1-2):42-9. PubMed ID: 16790329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Takakura Y
    J Control Release; 1999 Nov; 62(1-2):253-62. PubMed ID: 10518658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.